Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | CA2 | P00918 | 9/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 5/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26929049 | 0.92 | RECQL (0.48) | RECQLTSHRMAPK1GLAHPGD | |
| SCHEMBL6261279 | 0.84 | RECQL (0.39) | RECQLTSHRMAPK1GLAHPGD | |
| Sulfuric Acid SCHEMBL17102622 | 0.83 | DNM1 (0.46) | RECQLTSHRMAPK1GLAHPGD | |
| SCHEMBL4426717 | 0.83 | RECQL (0.58) | RECQLTSHRMAPK1GLAHPGD | |
| SCHEMBL3043679 | 0.82 | RECQL (0.47) | RECQLTSHRMAPK1GLAHPGD | |
| Sulfuric Acid SCHEMBL7175850 | 0.81 | DNM1 (0.44) | RECQLTSHRMAPK1GLAHPGD | |
| Sulfuric Acid SCHEMBL7175852 | 0.79 | DNM1 (0.42) | RECQLTSHRMAPK1DNM1CA2 | |
| Sulfuric Acid SCHEMBL7638910 | 0.79 | DNM1 (0.46) | RECQLTSHRMAPK1GLAHPGD | |
| SCHEMBL4427096 | 0.78 | TSHR (0.62) | RECQLTSHRMAPK1GLAHPGD | |
| Sulfuric Acid SCHEMBL27729946 | 0.78 | DNM1 (0.41) | RECQLTSHRMAPK1DNM1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7638636-B2 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC TECHNOLOGY CORP. (US) | 2009-12-29 | — | — | US | claimed |
| EP-1587813-B1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | CYTEC CANADA INC (CA) | 2007-10-03 | — | — | EP | claimed |
| US-20060264645-A1 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC CANADA INC. (CA) | 2006-11-23 | — | — | US | claimed |
| EP-1587813-A1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | Cytec Canada Inc. (CA) | 2005-10-26 | — | — | EP | claimed |
| CN-1675230-A | Phosphonium and imidazolium salts and methods for their preparation | CYTEC CANADA INC (CA) | 2005-09-28 | — | — | CN | claimed |
| WO-2004016631-A1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | CYTEC CANADA INC. (CA) | 2004-02-26 | — | — | WO | claimed |
| US-9147919-B2 | Methods of producing sulfate salts of cations from heteroatomic compounds and dialkyl sulfates and uses thereof | FLUIDIC, INC. (US) | 2015-09-29 | — | — | US | disclosed |
| US-7638636-B2 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC TECHNOLOGY CORP. (US) | 2009-12-29 | — | — | US | disclosed |
| EP-1587813-B1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | CYTEC CANADA INC (CA) | 2007-10-03 | — | — | EP | disclosed |
| US-20060264645-A1 | Phosphonium and imidazolium salts and methods of their preparation | CYTEC CANADA INC. (CA) | 2006-11-23 | — | — | US | disclosed |
| EP-1587813-A1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | Cytec Canada Inc. (CA) | 2005-10-26 | — | — | EP | disclosed |
| CN-1675230-A | Phosphonium and imidazolium salts and methods for their preparation | CYTEC CANADA INC (CA) | 2005-09-28 | — | — | CN | disclosed |
| WO-2004016631-A1 | PHOSPHONIUM AND IMIDAZOLIUM SALTS AND METHODS OF THEIR PREPARATION | CYTEC CANADA INC. (CA) | 2004-02-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264645-A1 | Phosphonium and imidazolium salts and methods of their preparation | PIK3R5, PHOSPHO1, PNISR | RECQL 140/4885TSHR 1922/4885MAPK1 603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.